TWA
SCPH

TCI Wealth Advisors’s scPharmaceuticals SCPH Stock Holding History

TCI Wealth Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-64
Closed – – 1654
2020
Q3 		$0 Buy
+64
New +$500 ﹤0.01% 1649
2019
Q1 		– Sell
-378
Closed -$1K – 1525
2018
Q4 		$1K Buy
378
+298
+373% +$1.4K ﹤0.01% 1298
2018
Q3 		$0 Buy
+80
New +$407 ﹤0.01% 1562

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

TCI Wealth Advisors's SCPH Position: Q4 2020 in Review

TCI Wealth Advisors sold out of scPharmaceuticals (SCPH) in Q4 2020, closing a stake of 64 shares.

TCI Wealth Advisors first reported a position in SCPH in Q3 2018 and held it in 3 quarters. The position peaked at $1K in Q4 2018. 47 funds tracked by Wall St. Rank hold SCPH as of Q4 2020.

  • TCI Wealth Advisors reported no remaining scPharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • TCI Wealth Advisors sold 64 scPharmaceuticals shares in Q4 2020.
  • TCI Wealth Advisors first reported a position in scPharmaceuticals in Q3 2018 and held it in 3 quarters.
  • TCI Wealth Advisors's scPharmaceuticals position peaked at $1K in Q4 2018.
  • 47 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2020.

Based on TCI Wealth Advisors's 13F filing for Q4 2020, filed 21 Jan 2021.